FDA-Drug2022-06-29Class II
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
Mayne Pharma Inc
Hazard
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Sold states
Nationwide in the US Market
Affected count
1440 cartons
Manufactured in
1240 Sugg Pkwy, Greenville, NC, United States
Products
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1152-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief